277 related articles for article (PubMed ID: 26504996)
1. Biocompatibility Assessment of Polyethylene Glycol-Poly L-Lysine-Poly Lactic-Co-Glycolic Acid Nanoparticles In Vitro and In Vivo.
Guo L; Chen B; Liu R; Xia G; Wang Y; Li X; Wei C; Wang X; Jiang H
J Nanosci Nanotechnol; 2015 May; 15(5):3710-9. PubMed ID: 26504996
[TBL] [Abstract][Full Text] [Related]
2. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
[TBL] [Abstract][Full Text] [Related]
3. The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility.
He Z; Wang Q; Sun Y; Shen M; Zhu M; Gu M; Wang Y; Duan Y
J Biomater Sci Polym Ed; 2014; 25(9):943-64. PubMed ID: 24811211
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
5. Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system.
Guo L; Zhang H; Wang F; Liu P; Wang Y; Xia G; Liu R; Li X; Yin H; Jiang H; Chen B
Int J Nanomedicine; 2015; 10():4535-47. PubMed ID: 26213467
[TBL] [Abstract][Full Text] [Related]
6. Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation.
Bao W; Liu R; Xia G; Wang F; Chen B
Drug Des Devel Ther; 2019; 13():1107-1115. PubMed ID: 31040647
[TBL] [Abstract][Full Text] [Related]
7. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
Liu P; Yu H; Sun Y; Zhu M; Duan Y
Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable tri-block copolymer poly(lactic acid)-poly(ethylene glycol)-poly(l-lysine)(PLA-PEG-PLL) as a non-viral vector to enhance gene transfection.
Fu C; Sun X; Liu D; Chen Z; Lu Z; Zhang N
Int J Mol Sci; 2011 Feb; 12(2):1371-88. PubMed ID: 21541064
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
[TBL] [Abstract][Full Text] [Related]
10. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil.
Liu P; Wang H; Wang Q; Sun Y; Shen M; Zhu M; Wan Z; Duan Y
J Nanosci Nanotechnol; 2012 Jun; 12(6):4467-71. PubMed ID: 22905486
[TBL] [Abstract][Full Text] [Related]
11. Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells.
Liu P; Zhang H; Wu X; Guo L; Wang F; Xia G; Chen B; Yin H; Wang Y; Li X
Onco Targets Ther; 2016; 9():5049-59. PubMed ID: 27574446
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of the genotoxicity of a family of novel MeO-PEG-poly(D,L-lactic-co-glycolic acid)-PEG-OMe triblock copolymer and PLGA nanoparticles.
He L; Yang L; Zhang ZR; Gong T; Deng L; Gu Z; Sun X
Nanotechnology; 2009 Nov; 20(45):455102. PubMed ID: 19822931
[TBL] [Abstract][Full Text] [Related]
13. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight PEG-PLGA polymers provide a superior matrix for conjugated polymer nanoparticles in terms of physicochemical properties, biocompatibility and optical/photoacoustic performance.
Abelha TF; Neumann PR; Holthof J; Dreiss CA; Alexander C; Green M; Dailey LA
J Mater Chem B; 2019 Sep; 7(33):5115-5124. PubMed ID: 31363720
[TBL] [Abstract][Full Text] [Related]
15. [Basic Research on Therapy of Leukemia with Nanoparticles Drug Delivery System Modified by Transferrin Receptor Monoclonal Antibody].
Bao W; Liu R; Wang F; Nie C; Qian LB; Chen L; Wang Y; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):939-944. PubMed ID: 37551459
[TBL] [Abstract][Full Text] [Related]
16. Degradation behavior and biosafety studies of the mPEG-PLGA-PLL copolymer.
He Z; Sun Y; Cao J; Duan Y
Phys Chem Chem Phys; 2016 Apr; 18(17):11986-99. PubMed ID: 27067001
[TBL] [Abstract][Full Text] [Related]
17. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
18. Investigation of PEG-PLGA-PEG nanoparticles-based multipolyplexes for IL-18 gene delivery.
Nie Y; Zhang ZR; He B; Gu Z
J Biomater Appl; 2012 May; 26(8):893-916. PubMed ID: 21273262
[TBL] [Abstract][Full Text] [Related]
19. Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors.
Khalili M; Zhou H; Thadi A; Daniels L; Fan Z; Morano WF; Ang J; Goldstein E; Polyak B; Mapow BC; Cheng H; Bowne WB
Ann Surg Oncol; 2020 Jan; 27(1):76-84. PubMed ID: 31187366
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]